1-9 of 9
Julie Chang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Ibrutinib Therapy Given after Prior Venetoclax Therapy in Ibrutinib-Naïve Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)

Jennifer R. Brown, MD PhD, Matthew S Davids, Julie Chang, Shuo Ma, MD PhD, Juliana Biondo, Mehrdad Mobasher, MD MPH, Yong Mun, PhD, Anthony R Mato, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5556.
https://doi.org/10.1182/blood-2018-99-116942
Published: 2018
Journal Articles

Assessment of Maintenance Rituximab after First-Line Bendamustine-Rituximab in Patients with Follicular Lymphoma: An Analysis from the BRIGHT Trial

Brad S Kahl, MD, John M. Burke, MD, Richard van der Jagt, MD FRCPC, Julie Chang, MD, Peter Wood, Tim Hawkins, FRACP, FRCPA, David MacDonald, Judith Trotman, MBChB, FRACP, FRCPA, David Simpson, MBChB, Kathryn S. Kolibaba, MD, Samar Issa, FRACP, Doreen Hallman, Ling Chen, Ian W. Flinn, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 484.
https://doi.org/10.1182/blood.V130.Suppl_1.484.484
Published: 2017
Journal Articles

A 3-Arm Randomized Phase II Trial with Bendamustine/Rituximab Therapy in Untreated High Risk (HR) Follicular Lymphoma (FL): Bortezomib Induction or Novel IMiD ® Continuation (BIONIC) Study from the ECOG-ACRIN Cancer Research Group

Andrew M Evens, DO,MSc, Fangxin Hong, PhD, Thomas M Habermann, MD, Ranjana H. Advani, MD, Randy D. Gascoyne, MD, Thomas E Witzig, MD, Andrew Quon, MD, Erik A. Ranheim, MD PhD, Puneet Cheema, MD, Philip Dy, MD, Timothy E. O'Brien, MD, Jane N. Winter, MD, Terrence Paul Cescon, Julie Chang, MD, Brad S Kahl, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 482.
https://doi.org/10.1182/blood.V130.Suppl_1.482.482
Published: 2017
Journal Articles

MLN9708, a Novel, Investigational Proteasome Inhibitor, in Patients with Relapsed/Refractory Lymphoma: Results of a Phase 1 Dose-Escalation Study

Sarit Assouline, MD, Julie Chang, MD, Robert Rifkin, MD, Ai-Min Hui, MD, Deborah Berg, RN, MSN, Neeraj Gupta, PhD, Yingmei Xi, PhD, Alessandra Di Bacco, PhD, Peter Martin, MD
Journal: Blood
Blood (2011) 118 (21): 2672.
https://doi.org/10.1182/blood.V118.21.2672.2672
Published: 2011
Journal Articles

miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy

Santiago Montes-Moreno, Nerea Martinez, Beatriz Sanchez-Espiridión, Ramon Díaz Uriarte, Maria Elena Rodriguez, Anabel Saez, Carlos Montalbán, Gonzalo Gomez, David G. Pisano, Juan Fernando García, Eulogio Conde, Eva Gonzalez-Barca, Andres Lopez, Manuela Mollejo, Carlos Grande, Miguel Angel Martinez, Cherie Dunphy, Eric D. Hsi, Gabrielle B. Rocque, Julie Chang, Ronald S. Go, Carlo Visco, Zijun Xu-Monette, Ken H. Young, Miguel A. Piris
Journal: Blood
Blood (2011) 118 (4): 1034–1040.
https://doi.org/10.1182/blood-2010-11-321554
Published: 2011
Includes: Supplemental data
Journal Articles

The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation

Clinical Trials & Observations
Davide Rossi, Valeria Spina, Clara Deambrogi, Silvia Rasi, Luca Laurenti, Kostas Stamatopoulos, Luca Arcaini, Marco Lucioni, Gabrielle B. Rocque, Zijun Y. Xu-Monette, Carlo Visco, Julie Chang, Ekaterina Chigrinova, Francesco Forconi, Roberto Marasca, Caroline Besson, Theodora Papadaki, Marco Paulli, Luigi M. Larocca, Stefano A. Pileri, Valter Gattei, Francesco Bertoni, Robin Foà, Ken H. Young, Gianluca Gaidano
Journal: Blood
Blood (2011) 117 (12): 3391–3401.
https://doi.org/10.1182/blood-2010-09-302174
Published: 2011
Journal Articles

The Molecular Profile of Richter Syndrome Predicts Survival From Transformation: The Role of Clonal Relationship

Davide Rossi, Valeria Spina, Clara Deambrogi, Silvia Rasi, Luca Laurenti, Kostas Stamatopoulos, Luca Arcaini, Marco Lucioni, Gabrielle R. Rocque, Zijun Y. Xu-Monette, Carlo Visco, Julie Chang, Ekaterina Chigrinova, Francesco Forconi, Roberto Marasca, Caroline Besson, Theodora Papadaki, Marco Paulli, Luigi M. Larocca, Stefano A. Pileri, Valter Gattei, Francesco Bertoni, Robin Foà, Ken H. Young, Gianluca Gaidano
Journal: Blood
Blood (2010) 116 (21): 3601.
https://doi.org/10.1182/blood.V116.21.3601.3601
Published: 2010
Journal Articles

Phase I Study of the Oral Histone Deacetylase Inhibitor SB939 In Patients with Advanced Hematologic Malignancies

Guillermo Garcia-Manero, MD, Charles Chuah, MBChB, FRCPE, MD, George Wilding, Julie Chang, MD, Srdan Verstovsek, MD, PhD, Stefan Faderl, MD, Hagop M. Kantarjian, MD, Kantharaj Ethirajulu, Joy Zhu
Journal: Blood
Blood (2010) 116 (21): 3292.
https://doi.org/10.1182/blood.V116.21.3292.3292
Published: 2010
Journal Articles

VcR-CVAD Produces a High Complete Response Rate in Untreated Mantle Cell Lymphoma: A Phase II Study from the Wisconsin Oncology Network

Brad Kahl, Julie Chang, Jens Eickhoff, Leslie Gilbert, Eric Rogers, Jae Werndli, Michael Huie, Thomas McFarland, Michael Volk, Jules H. Blank, Natalie Callander, Walter Longo, Christopher Peterson
Journal: Blood
Blood (2008) 112 (11): 265.
https://doi.org/10.1182/blood.V112.11.265.265
Published: 2008